Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heart & Soil is a leading health and wellness company specializing in desiccated organ supplements sourced from grass-fed, regeneratively raised cattle. Founded in 2020 by Dr. Paul Saladino, the company advocates for a "nose-to-tail" ancestral diet to restore human health and vitality. Their product line features freeze-dried organ blends, including liver, heart, kidney, and bone marrow, which are processed at low temperatures to preserve bioavailable vitamins, minerals, and unique peptides. Heart & Soil operates as a high-growth direct-to-consumer brand, emphasizing ethical sourcing from farms in New Zealand and the United States. The company has rapidly scaled to become a significant player in the nutraceutical space, driven by a mission to help individuals reclaim their radical health through ancestral nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heart + Soil.